Cleared Traditional

K243003 - VitalSigns 1-Lead Holter (VSH101)

K243003 is an FDA 510(k) clearance for VitalSigns 1-Lead Holter (VSH101), manufactured by VitalSigns Technology Co., Ltd.. The device is a Class 2 Cardiovascular device with product code DXH cleared through the Traditional 510(k) pathway after a 264-day FDA review.

K243003 · VitalSigns Technology Co., Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2025
Decision
264d
Days
Class 2
Risk

K243003 is an FDA 510(k) clearance for the VitalSigns 1-Lead Holter (VSH101). Classified as Transmitters And Receivers, Electrocardiograph, Telephone (product code DXH), Class II - Special Controls.

Submitted by VitalSigns Technology Co., Ltd. (Hsinchu County, TW). The FDA issued a Cleared decision on June 17, 2025 after a review of 264 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2920 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all VitalSigns Technology Co., Ltd. devices

FDA 510(k) Submission Details - K243003

510(k) Number K243003 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 26, 2024
Decision Date June 17, 2025
Days to Decision 264 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
139d slower than avg
Panel avg: 125d · This submission: 264d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXH Device Classification - Class 2, Special Controls

Product Code DXH Transmitters And Receivers, Electrocardiograph, Telephone
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2920
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXH Transmitters And Receivers, Electrocardiograph, Telephone

All 116
Devices cleared under the same product code (DXH) and FDA review panel - the closest regulatory comparables to K243003.
HeartBeam AIMIGo with 12-L ECG Synthesis Software System
K250258 · Heartbeam, Inc. · Dec 2025
MEMO Patch M (MPT-E08R-UNC01)
K243438 · Huinno Co., Ltd. · Dec 2025
Hexoskin Medical System (7100-00016)
K243981 · Carre Technologies, Inc. · Nov 2025
QT ECG (QTERD100)
K233521 · QT Medical, Inc. · Dec 2023
V-Patch Cardiac Monitor
K222842 · Shandong Corecare Technology Limited · Oct 2022
QT ECG
K220795 · QT Medical, Inc. · Sep 2022